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Abstract Purpose: To report an un-
usual case of almost simultaneous
bilateral rhegmatogenous retinal de-
tachment in the context of external-
beam radiotherapy for a tumor at a
non-ocular target site and in the ab-
sence of pre-existing ocular patholo-
gy. Methods: Observational case re-
port with review of corresponding
literature. Results: A 63-year-old man
was referred for bilateral retinal de-
tachment which was associated with
many horseshoe tears and prolifera-
tive vitreoretinopathy. He had un-
dergone surgery for a carcinoma of
the left maxillary sinus 4 months
prior to the presentation and had then
received external-beam radiotherapy
for 3 months. There was no familial
history of retinal detachment and/or
eye trauma in this hyperopic patient
with clear native lenses. No chorio-
retinal pathology was apparent that
could have predisposed the retinas to
tearing. Conclusions: Simultaneous
bilateral retinal detachment is excep-
tional, especially in a patient with no
risk factors. The effect of radiother-
apy on the vitreoretinal interface is
discussed in the light of existing data
and may have been responsible for
our patient’s retinal detachment.
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Introduction
Rhegmatogenous retinal detachment (RD) is not an ac-
knowledged complication of ocular radiation, although
such cases have been reported [9, 11]. Indeed, the possi-
bility of a correlation has not been systematically ad-
dressed. Following the few published cases, we present
here the first report of bilateral rhegmatogenous RD with
proliferative vitreoretinopathy (PVR) after external-beam
radiotherapy for a tumor at a non-ocular site, in this case a
carcinoma of the left maxillary sinus. The clinical features
of this remarkable case are described and the possible
pathological mechanisms underlying it are discussed.
Case report
A 63-year-old man was referred to our hospital for bilateral rheg-
matogenous RD on 27 August 2002. He had noted the existence of
floaters and a deterioration in visual acuity, first of the left eye (8
weeks prior to presentation) and then of the right eye (2 weeks prior
to presentation). He had undergone surgery for a carcinoma of the
left maxillary sinus in May 2002 and had then received external-
beam radiotherapy from 19 June 2002 until 5 August 2002. He was
administered a total photon (X-ray) dose of 66 Gy. Despite the
utmost care to minimize ocular exposure to radiation, this never-
theless had occurred to a significant degree. The left vitreoretinal
interface had incurred a dose of 36–45 Gy, the right, 10–15 Gy
(Fig. 1).
There was no familial history of RD or eye trauma in this
hyperopic patient with clear native lenses. Examination of the right
fundus revealed the presence of a macula-sparing RD involving the
superior half of the retina, with five horseshoe tears and PVR
(grade B). In the left eye, the RD only just spared the macula; it was
characterized by four horseshoe tears and PVR (grade B). No
chorioretinal pathology was apparent that could have predisposed
the retinas to tearing. Posterior detachment of the vitreous was
complete in both eyes, except in the meridian of three retinal tears
(in each eye), where it adhered to the anterior flap of the tear in the
absence of scleral pressure. Clusters of pigmented cells were ap-
parent in the vitreous of both eyes (“tobacco dust”). Examination of
the fundus 1 year prior to external-beam radiotherapy had revealed
no pathological findings. Standard ultrasonography performed in
August 2002 disclosed no chorioretinal tumor. The carcinoma of
the sinus was clinically quiescent and was deemed to have been
successfully treated. A work-up for metastases yielded negative
results. Ocular surgery was successfully performed first on the right
eye (buckling surgery using cerclage) and 2 weeks later on the left
eye (vitrectomy and cerclage), by which time the PVR had in-
creased from grade B to grade C1 (Fig. 2). Unfortunately the vit-
rectomy material was not submitted to cytological examination.
Discussion
This case is of particular in interest in being the first
documented instance of bilateral rhegmatogenous RD
development after external-beam radiotherapy for a tumor
at a non-ocular target site and in the absence of pre-ex-
isting ocular pathology.
In the context of external-beam radiotherapy, serous
RD has been observed as a complication either of me-
tastasis or of the therapy itself of intraocular malignancies
[2, 9, 10], but has never been reported for extraocular
malignancies without any ocular involvement. However,
in our case, clinical examination and ultrasonography
excluded the presence of a chorioretinal tumor. Further-
more, numerous retinal tears were observed, the surgical
repair of which resulted in prompt and complete bilateral
retinal reattachment. This latter circumstance supports the
diagnosis of rhegmatogenous RD.
Fig. 1 Isodose curves on a computed tomographic scan, revealing
the irradiation field for each eye
Fig. 2 Fundus photograph of the left eye 1 month after surgery,
illustrating the reattached retina with a star fold (due to proliferative
vitreoretinopathy) close to the temporal inferior vessels
525
RD arising from retinal breaks occurs in about 12 per
100,000 persons annually, and in half as many non-trau-
matic phakic patients [8]. Bilateral RD has been estimated
to occur in 2 per 1,000,000 phakic persons per year [8]. In
most of the articles dealing with bilateral RD, however,
the authors do not distinguish between simultaneous and
delayed development in the second eye. In our experi-
ence, the incidence of simultaneous bilateral RD is cer-
tainly much lower, and probably highly exceptional. In
one study, the incidence of bilateral RD is reported to be
13% and that of simultaneous bilateral RD only 1.4% [4].
In another report, only one patient (0.4%) at a particular
retina centre was diagnosed with simultaneous bilateral
RD over a period spanning 8.5 years [3]. That patient’s
high myopia (12 D) was believed to be the disposing
factor. Indeed, such risk factors are regularly reported for
patients with bilateral RD, and include also chorioretinal
lesions (such as lattice degeneration or focal pigmentary
proliferation), cataract surgery, advanced age, familial
antecedents of RD and/or eye trauma [3, 5]. Our patient,
however, fell into none of these categories. Moreover, the
RD was highly exceptional in that occurred almost si-
multaneously in both eyes, first in the eye that had re-
ceived the higher dose of radiation. In this eye, PVR was
also more severe. Hence, the bilateral rhegmatogenous
RD in this specific case may be considered as an ocular
side-effect of extraocular radiotherapy, not merely a co-
incidence.
Little has been reported about the effects of radio-
therapy on the vitreous and the vitreoretinal interface.
Radiation could conceivably have induced contraction and
detachment of the vitreous. Clinically, posterior detach-
ment of the vitreous was virtually complete in both of our
patient’s eyes at the time of surgery, with vitreal traction
being evident on some of the tears. Theoretically, radio-
therapy could also have altered the vitreoretinal interface,
inducing or reinforcing adhesions between the posterior
vitreal cortex and the internal limiting membrane of the
retina, and thereby enhancing the risk of retinal tearing [2].
Remarkably, abnormal deposits of fibrin have been en-
countered in histopathological sections of 33 eyes that had
undergone radiotherapy for retinoblastomas [6]. These
occurred not only intra- but also extra-vascularly, within
the retinal stroma, and they could conceivably have in-
duced strong vitreoretinal adhesion. No correlation was
found to exist between the severity of fibrin proliferation
and the radiation dose delivered or the age of the patient.
Moreover, there existed no corresponding retinal changes
in the control non-irradiated eyes, which confirmed that
the deposits of fibrin were related not to the underlying
disease but to the radiotherapy. Such fibrin deposits were
not visible biomicroscopically in our patient. In another
histopathological report dealing with the morphological
changes induced by fractionated external-beam radio-
therapy in the eyes of minipigs, a homogeneously dis-
tributed layer of collagen fibrils appeared on the vitreal
aspect of the inner limiting membrane and was believed to
have enhanced the adhesion of the interface to the retina
[1]. Radiation is also known to have a direct impact on
retinal pigmented epithelial (RPE) cells, animal experi-
ments having revealed a dose-dependent effect on their
morphology and proliferation [1]. These morphological
changes might impair the adhesion of epithelial cells to the
sensory retina and Bruch’s membrane. In our patient, such
changes could have facilitated the induction of RD by
retinal tearing, which in turn resulted from vitreal con-
traction. In the histopathological study reported by Alberti
and El-Hifnawi, local hypertrophy of the RPE cells was
also observed in some eyes [1]. In our patient, this phe-
nomenon may have accounted for the abundance of pig-
mented cells within the vitreous of both eyes and may
have contributed to an amplified proliferative response of
these cells and to the rapid evolution of the PVR [1].
Indeed, RPE cells have been recognized to be a major
component of contractile cellular membranes in PVR [7].
They may be responsible for induction of PVR, since in-
travitreal injection of RPE cells in rabbits results in cel-
lular membrane formation and traction RD similar to that
seen in PVR [13]. One could argue that radiotherapy is
known to suppress rather than exacerbate PVR in the ex-
perimental setting [12]. In experiments with rabbits, ocular
irradiation after the injection of fibroblasts or RPE cells
into the vitreous did indeed suppress PVR and tractional
RD, but radiotherapy performed before cell implantation
was not effective in this capacity [16]. Furthermore, ra-
diotherapy does not suppress traumatic PVR [15]. Clearly,
several parameters may influence the effect of radiother-
apy on vitreal and retinal structures, but our patient was
obviously the victim of radiation-induced vitreoretinal
traction, with consequent rhegmatogenous RD and PVR.
It would of course be wrong to assume that a temporal
relationship between two events, necessarily implies a
causal link. However, several arguments favor a non-co-
incidental nature of the relationship between radiotherapy
and the development of bilateral rhegmatogenous RD in
our patient, including the almost simultaneous occurrence
of the disease in both eyes and the pathophysiological
evidence for the deleterious effects of radiation on the
vitreous, the vitreoretinal interface and retinal cells. One
could argue that if radiation was indeed the culprit, then
thousands of patients who have received radiotherapy for
uveal melanomas should have developed rhegmatogenous
RD. Excluding articles that deal with the simultaneous
diagnosis of choroidal melanomas and RD, we unearthed
no documented evidence of this complication of radiation
in the literature, with but two exceptions. The Harvard
Cyclotron Team in Boston reported six cases of rheg-
matogenous RD development after either proton-beam
irradiation (five patients) or 125I plaque radiotherapy (one
patient) [9]. The Wills Eye Hospital in Philadelphia
reported on 270 patients who had been treated for cho-
roidal melanomas by combined plaque radiotherapy and
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transpupillary thermotherapy and furnished a more pre-
cise estimation of the occurrence of this complication
[14]. Kaplan–Meier estimates of the rate of rhegmatoge-
nous RD were 2% at 2 and 5 years. This rate is not
negligible and argues in favor of our assumption. Hith-
erto, the rate of rhegmatogenous RD following radio-
therapy may have been underestimated because physi-
cians were not aware of the problem. Indeed, recently a
suspected relationship between rhegmatogenous RD and
radiotherapy for retinoblastomas has been reported [11].
After careful consideration of all the above-mentioned
literature, there appears to be histopathological evidence
from retinoblastoma and animal models, and epidemio-
logical evidence from uveal melanoma, that rhegmatog-
enous RD is a result not of the initial pathology but of the
radiotherapy. To the best of our knowledge, our patient
represents the first documented case of bilateral rheg-
matogenous RD development after irradiation of a non-
ocular target site.
We finally assume that our patient must have been
exceptionally sensitive to radiation, since no similar case
has been reported hitherto. Although a single case report
does not carry much weight, we would like to stress that a
relationship may well exist between ocular irradiation and
rhegmatogenous RD. We encourage physicians to observe
their patients closely for symptoms of the disease in this
context.
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